Aerska

Bioscience & Disease Healthcare Systems Deep Tech

Bioscience & Disease Healthcare Systems +1

@AerskaBiotech Website LinkedIn Dublin, Ireland

About Aerska

Aerska is a biotechnology startup pioneering the development of systemically administered RNA interference (RNAi) medicines aimed at treating, delaying, and preventing diseases of the brain. The company focuses on overcoming the challenges of delivering genetic medicines across the blood-brain barrier.

Business Information

Target Customers

pharmaceutical companies research institutions healthcare providers

Industry Categories

Bioscience & Disease Healthcare Systems Deep Tech

Business Model

Revenue Model Partnerships and licensing

Pricing Strategy N/A

Sales Channels direct sales, partnerships

Funding Timeline

Round	Date	Amount	Investors
Series A	Feb 09, 2026	$39.0M	eqt Dementia Fund, @age1vc
Series A	Feb 09, 2026	$60.0M	eqt Dementia Fund
Seed	Nov 04, 2025	$21.0M	@age1vc, @BackedVC, Speedinvest

Founders

Jack O’Meara

Co-Founder & CEO

Jack O'Meara

CEO & Co-founder

Investors

@BackedVC

Venture Capital

@age1vc

Venture Capital

Speedinvest

Venture Capital

eqt Dementia Fund

Venture Capital

Recent Mentions

Entrepreneurs First @join_ef

Nov 04, 2025

3/ Aerska (Jack O’Meara CEO) raises $21M in Seed round Aerska has raised $21M in Seed funding, with the latest round co-led by @age1vc, @BackedVC and @speedinvest. Founded in 2025, the Dublin-based biotech startup is developing systemically administered RNA interference (RNAi) https://t.co/SSDxwNeCxt

View on Twitter

BACKED 🏴 @BackedVC

Feb 09, 2026

We’re backing a future we want to be a part of. Congratulations to @Jack_O_Meara and the entirety of the Aerska team on closing their Series A less than a year after closing their seed round, bringing total funding since launch to $60m. The round is co-led by @eqt Dementia Fund https://t.co/BOYarEvITY

View on Twitter

Raising.fi @raisingfi

Feb 09, 2026

🏛️ Company: Aerska 🔗 Website: https://t.co/nw1pptJjHY 📊 Amount: $39 Million 🔄 Round: Series A ⚙️ Industry: Biotechnology 🌍 Location: Dublin, Ireland

View on Twitter

SynBioBeta @SynBioBeta

Feb 23, 2026

Irish biotech Aerska has raised $39 million in a Series A funding round led by EQT Dementia Fund and age1, bringing its total funding to $60 million. The capital will enhance its proprietary brain shuttle technology aimed at delivering RNA interference therapeutics across the https://t.co/XNy9AEF43C

View on Twitter

Similar Startups

stealthy AI biotech startup

87% match

Xaira Therapeutics is a biotech startup utilizing AI for drug discovery, aiming to revolutionize the...

Aureka Biotechnologies

87% match

Aureka Biotechnologies focuses on AI-driven antibody design, committed to democratizing the pharmace...

SanegeneBio

86% match

A clinical-stage biotech developing RNAi therapeutics with a focus on creating targeted therapies fo...

AeroRx Therapeutics

86% match

AeroRx Therapeutics is a clinical-stage biopharmaceutical startup focused on developing proprietary,...